Synthesis and structure-activity relationships of open D-Ring galanthamine analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 13, Issue 14, 2003, Pages 2389-2391

  Herlem, Denyse ^a   Martin, Marie Thérèse ^a   Thal, Claude ^a   Guillou, Catherine ^a  

^a INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CHOLINESTERASE; GALANTAMINE; OXAZOLIDINE DERIVATIVE; URETHAN;

ARTICLE; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENZYME INHIBITION; RING OPENING;

EID: 0038680414     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(03)00397-4     Document Type: Article

References (25)

1. (a) Harvey A.L. Pharma. Ther. 68:1995;113.
2. (b) Mucke H.A.M. Drugs Today. 33:1997;251.
3. (c) Kewitz H. Drugs Today. 33:1997;265.
4. (d) Rainer M. Drugs Today. 33:1997;273.
5. (a) Sweeney T., Kewitz H. Life Sci. 46:1990;1553.
6. (b) Thomsen T., Bickel U., Fischer J.P., Kewitz H. Eur. J. Clin. Pharmacol. 39:1990;603.
7. Han S.Y., Sweeney J.E., Bachman E.S., Schweiger E.J., Forloni G., Coyle J.T., Davis B.M., Joullié M.M. Eur. J. Med. Chem. 27:1992;673.
8. (a) Poschalko A., Welzig S., Treu M., Nerdinger S., Mereiter K., Jordis U. Tetrahedron. 58:2002;1513.
9. (b) Treu M., Jordis U., Mereiter K. Heterocycles. 55:2001;1727.
10. Bores G.M., Kosley R.W. Jr. Drugs Future. 21:1996;621.
11. (a) Novel galanthamine derivatives: Thal, C.; Guillou, C.; Mary, A.; Renko, D. Z.; Potier, P.; Christen, Y. PCT Int. Appl. WO 97 03,987, 19 July 1996, GB Appl.95/14821.9, 19 July 1995.
12. (b) Mary A., Renko D.Z., Guillou C., Thal C. Bioorg. Med. Chem. 6:1998;1835
13. (c) Guillou C., Mary A., Renko D.Z., Thal C. Bioorg. Med. Chem. Lett. 10:2000;637.
14. (a) Santos M.D., Alkondon M., Pereira E.F.R., Aracava Y., Eisenberg H.M., Maelicke A., Albuquerque E.X. Mol. Pharmacol. 61:2002;1222
15. (b) Lilienfield S. CNS Drug Reviews. 8:2002;159.
16. Von Angerer S., Von Angerer E., Ambros R., Wiegrebe W. Arch. Pharm. 325:1992;425.
17. Kobayashi S., Satoh K., Numata A., Shingu T., Kihara M. Phytochemistry. 30:1991;675.
18. Bremner J.B., Browne E.J., Davies P.E., Van Thuc L. Aust. J. Chem. 33:1980;833. and references cited herein.
19. Ellman G.L., Courtney K.D., Andres V., Featherstone R.M. Biochem. Pharmacol. 7:1961;88.
20. Greenblatt H.M., Kryger G., Lewis T., Silman I., Sussman J.L. FEBS Lett. 463:1999;321.
21. (a) Munoz F.J., Aldunate R., Inestrosa N.C. Neuroreport. 10:1999;3621
22. (b) Johnson G., Moore S.W. Biochem. Biophys. Res. Commun. 258:1999;758
23. (c) Contreras C.F., canales M.A., Alvarez A., De Ferrari G.V., Inestrosa N.C. Protein Ing. 12:1999;959
24. (d) De Ferrari G.V., Canales M.A., Shin I., Weiner L.M., Silman I., Inestrosa N.C. Biochemistry. 40:2001;10447.
25. Hardy J.A., Higgins G.A. Science. 256:1992;184.